204 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry

4104

Excelsior Medical
NT$89.80-6.7%11.6%NT$14.7bn/aPE18.7xn/a4.2%Healthcare

4174

OBI Pharma
NT$60.80-2.7%-28.5%NT$13.9bn/aPS335.5xn/an/aPharmaceuticals & Biotech

4162

PharmaEngine
NT$93.60-3.6%-4.7%NT$13.4bn/aPE49xn/a1.6%Pharmaceuticals & Biotech

6576

Foresee Pharmaceuticals
NT$97.00-2.4%4.8%NT$13.2bNT$153.00PS67.5xn/an/aPharmaceuticals & Biotech

3705

YungShin Global Holding
NT$48.00-0.9%8.4%NT$13.0bn/aPE15.5xn/a4.8%Pharmaceuticals & Biotech

4746

Formosa Laboratories
NT$101.00-10.6%25.0%NT$12.8bNT$137.50PE96.2xS13.9%2.0%Pharmaceuticals & Biotech

4728

Sunmax Biotechnology
NT$228.00-2.6%-11.8%NT$12.4bn/aPE19.8xn/a4.2%Pharmaceuticals & Biotech

6586

CHO Pharma
NT$57.50-1.0%-47.7%NT$12.3bn/aPB4.1xn/an/aPharmaceuticals & Biotech

4142

Adimmune
NT$27.302.8%-31.9%NT$12.0bn/aPS6.4xn/a0%Pharmaceuticals & Biotech

4157

TaiGen Biopharmaceuticals Holdings
NT$15.755.4%5.0%NT$11.3bn/aPE82.7xn/an/aPharmaceuticals & Biotech

1720

Standard Chemical & Pharmaceutical
NT$61.00-5.0%-4.8%NT$11.1bn/aPE13.1xn/a4.4%Pharmaceuticals & Biotech

4119

SCI Pharmtech
NT$86.50-2.3%-23.1%NT$10.6bn/aPE35.1xn/a1.4%Pharmaceuticals & Biotech

4164

CHC Healthcare Group
NT$55.80-6.2%-16.8%NT$9.7bNT$71.00PE22.2xE26.3%3.6%Healthcare

1565

St.Shine OpticalLtd
NT$183.50-3.2%-27.0%NT$9.3bNT$197.00PE16.9xS5.8%3.8%Healthcare

4726

Mycenax Biotech
NT$44.907.8%18.2%NT$9.2bn/aPS14.2xn/an/aPharmaceuticals & Biotech

4107

Bioteque
NT$126.00-0.4%11.5%NT$8.7bn/aPE19.3xn/a3.6%Healthcare

1760

Panion & Bf Biotech
NT$96.50-7.2%-41.3%NT$8.7bn/aPE107.1xn/a1.6%Pharmaceuticals & Biotech

6841

Ever Fortune.AI
NT$88.50-3.3%-22.0%NT$8.6bNT$130.00PS91.5xn/a2.3%Healthcare

4129

United Orthopedic
NT$95.10-1.8%60.4%NT$8.3bNT$126.00PE22xn/a4.2%Healthcare

1799

Easywell Biomedicals
NT$66.701.1%231.8%NT$8.1bn/aPS29.9xn/an/aHealthcare

6875

Pharmosa Biopharm
NT$69.00-13.5%-14.6%NT$8.1bn/aPE956.4xn/an/aPharmaceuticals & Biotech

6541

Tanvex BioPharma
NT$46.10-4.5%-40.7%NT$7.7bn/aPS123.1xn/an/aPharmaceuticals & Biotech

6949

PELL Bio-Med Technology
NT$149.0019.2%n/aNT$7.7bn/aPS445.7xn/an/aPharmaceuticals & Biotech

1786

SciVision Biotech
NT$104.00-4.1%44.4%NT$7.3bn/aPE39.6xn/a2.4%Healthcare
Page 2 of 9
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.